230P Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study
- H. YıldırımE. Mutlu S. Aksoy
- 1 May 2023
Medicine
Response and tolerability of palbociclib plus fulvestrant in breast cancer patient with bone marrow metastasis and cytopenia: A case report
- E. Mutlu
- 2022
Medicine
Mother Tongue Education of Turkish Minority in Bulgaria
- E. MutluSuzan Kavanoz
- 2010
Education, Sociology
Risk factors for 30-day mortality in patients with cancer and COVID-19 in Turkey: A single Center retrospective study
High incidence of cancer and the risk of immunosuppression in these patients increased the importance of COVID-19 and they need to be treated more carefully because they are vulnerable to infection and can be mortal.
Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: A multicenter study
- H. YıldırımE. Mutlu S. Aksoy
- 1 September 2022
Medicine
The results support the use of CDK 4–6 inhibitor-based combinations in the first-line treatment of HR+ and HER2-metastatic female breast cancer and the treatment responses of metastatic HR+, Her2-male breast cancer patients treated with CDK4–6 inhibitors.
Effect of process parameters on the weld quality of 3D printed PLA‐CF sheets by FSW process
- Nergizhan AnaçOğuz Koçar S. Siengchin
- 22 February 2025
Materials Science, Engineering
Friction stir welding (FSW) process is commonly used in the joining of similar/dissimilar materials. FSW involves process parameters that can affect the weld quality. To enhance this, it is important…